Targeted ultrasonic contrast agents for molecular imaging and therapy
- 18 December 2003
- journal article
- review article
- Published by Elsevier in Current Problems in Cardiology
- Vol. 28 (12), 625-653
- https://doi.org/10.1016/j.cpcardiol.2003.11.001
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticlesMagnetic Resonance in Medicine, 2000
- Acoustically Active Lipospheres Containing PaclitaxelInvestigative Radiology, 1998
- In Vitro Targeting of Antibody-Conjugated Echogenic Liposomes for Site-Specific Ultrasonic Image EnhancementJournal of Pharmaceutical Sciences, 1997
- Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in ratsHepatology, 1996
- Development of Inherently Echogenic Liposomes as an Ultrasonic Contrast Agent†Journal of Pharmaceutical Sciences, 1996
- Gas-Filled Lipid Bilayers as Ultrasound Contrast AgentsInvestigative Radiology, 1994
- Immunoscintigraphy with three step monoclonal pretargeting technique in diagnosis of uveal melanoma: preliminary results.British Journal of Ophthalmology, 1994
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Membrane fusion and inverted phasesBiochemistry, 1989
- Destabilization of phosphatidylethanolamine-containing liposomes: hexagonal phase and asymmetric membranesBiochemistry, 1987